Rojee Maharjan
Family · Methuen, MANPI 1366004145
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 332 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 332 payments — averaging $18.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- AstraZeneca$777
- E.r. Squibb & Sons, L.L.C.$743
- Pfizer$491
- Amgen$373
- Bayer$345
- plus $2K from 24 others
What the payments were for
- Food & beverage$6,249100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 69 | $1,187 |
| AstraZeneca | 42 | $777 |
| E.r. Squibb & Sons, L.L.C. | 39 | $743 |
| Pfizer | 25 | $491 |
| Amgen | 20 | $373 |
| Bayer | 18 | $345 |
| AbbVie | 14 | $296 |
| Merck | 17 | $287 |
| Johnson & Johnson | 15 | $279 |
| Novo Nordisk | 12 | $240 |
| Boehringer Ingelheim | 11 | $211 |
| Kiniksa Pharmaceuticals, Ltd. | 4 | $96 |
| Heartflow, Inc. | 3 | $95 |
| Exact Sciences | 5 | $92 |
| Lilly USA, LLC | 4 | $89 |
| Esperion Therapeutics, Inc. | 5 | $81 |
| Amarin Pharma, Inc. | 4 | $79 |
| Scpharmaceuticals Inc. | 4 | $69 |
| Alnylam Pharmaceuticals Inc. | 3 | $56 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $54 |
| Mylan Specialty L.p. | 3 | $47 |
| Cvrx, Inc. | 2 | $46 |
| Janssen Scientific Affairs, LLC | 1 | $41 |
| CMP Pharma, Inc. | 2 | $39 |
| Actelion Pharmaceuticals US, Inc. | 2 | $30 |
| Philips North America LLC | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| Ionis Pharmaceuticals, Inc. | 1 | $17 |
How this compares
$6,249 in reported general payments places this provider in the 95th percentile of 2,320 family providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 40 | $57,369 |
| EntrestoSacubitril/Valsartan | 48 | $48,897 |
| Atorvastatin Calcium | 88 | $1,741 |
| Potassium Chloride | 20 | $1,738 |
| Metoprolol Succinate | 70 | $1,190 |
| Ezetimibe | 16 | $1,034 |
| SynthroidLevothyroxine Sodium | 12 | $569 |
| Lisinopril | 82 | $505 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 19 | $449 |
| Losartan Potassium | 34 | $362 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $289 |
| Furosemide | 56 | $247 |
| Gabapentin | 18 | $227 |
| Simvastatin | 22 | $192 |
| Omeprazole | 20 | $183 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $491 | $57,36940 claims |
| NovartisEntresto | $1,187 | $48,89748 claims |
| AbbVieSynthroid | $296 | $56912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,320 family providers in Massachusetts.
Other family in Methuen
- Paul GouldLakeville$343K
- Brittany MurrayBoston$141K
- Jennifer FlemingLawrence$80K
- Naomi AmudalaBoston$79K
- Geoffrey WhitleyCharlestown$66K
- Katherine O'BrienWinthrop$58K
- Kristy SmithActon$57K
- Leslie StefanowiczDartmouth$56K
- Marissa CasilloFoxborough$31K
- Rochelle NazarianDanvers$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.